Testing effectiveness (Phase 2)Active Not RecruitingNCT06145282
What this trial is testing
Non-myeloablative Haploidentical HCT Study for Patients With Sickle Cell Disease, Including Compromised Organ Function
Who this might be right for
Sickle Cell Disease
National Heart, Lung, and Blood Institute (NHLBI) 6